ORION-10 was the second of three 19-month Phase III clinical trials for inclusion for lowering cholesterol. Funded by sponsor The Medicines Company, a week after the sponsor announced the actual study data Novartis announced that it was paying $9.7 billion to buy the...
Researchers at the NYU School of Medicine perform study that “provides the ‘first direct evidence’ that raising levels of a simple, functional version of good cholesterol – the HDL protein shuttle that pulls cholesterol out of cells – reversed the...
Janice Wood of PsychCentral reports that new research has uncovered a link between high LDL cholesterol levels and early-onset Alzheimer’s disease. Based on these results, doctors could gain deeper insight as to how the disease develops and an exploration of potential...
St. Michael’s Hospital, Toronto, Canada sponsored a study recently as the U.S. Food and Drug Administration had plans to remove soy from its list of healthy foods for the heart. The Canadian researchers, via the St. Michael’s Hospital, conducted a meta-analysis of 46...
The University of Nottingham, UK conducted a study suggesting statins are ineffective at lowering cholesterol to target levels in more than half of patients. Published in the journal Heart, the UK researchers found 51.2% of patients prescribed statins saw minimal...
Baylor College of Medicine researchers took part in the CLEAR (Cholesterol Lowering via bempedoic Acid, an ACL-inhibiting Regimen) Harmony trial have found that while the new drug, bempedoic acid, where taken over approximately a year, did cause some adverse effects,...
